Institutional Dynamics:

Institutional Dynamics: 

• Monsanto's Agricultural Model:
  Monsanto developed a system that combines genetically modified seeds, specifically the Roundup Ready soybean, with their herbicide glyphosate. This innovation has created a highly integrated agricultural model that claims to improve weed management and crop yields.

• Lobbying Efforts:
  Monsanto has actively lobbied politicians to influence legislation in ways that compel farmers to purchase their seeds. This includes mechanisms like the "Monsanto Protection Act" and legal precedents that restrict farmers' rights to save and reuse seeds.

• Major Shareholders:
  The biggest shareholders of Monsanto include BlackRock, Vanguard, and State Street.

​

Business:

• Chemical Compounds:
  Modern food companies introduce new chemical compounds designed for:

  • Long Shelf Life: Products that are non-perishable and resistant to decomposition.

  • Health Implications: These compounds may not be acute toxins, but their long-term effects on health are largely unknown.

• Consumer Impact:

  • Addiction: Processed foods can lead to long-term health issues and depleting nutrition over time.

  • Convenience vs. Nutrition: The convenience of processed foods makes it more challenging for consumers to obtain proper nutrition.

• Profit Prioritization:
  Companies prioritize profits driven by stakeholders. CEOs are often elected by major stakeholders, such as BlackRock, Vanguard, and State Street. This pressure can lead to a focus on short-term results due to stock market demands.

​

​​​Regulatory bodies:

• Influence on Regulatory Bodies:
  Government institutions like the FDA, USDA, American Heart Association (AHA), and CDC have approved or recommended harmful ingredients in our food supply. Many board members of these organizations come from large corporations.

• Safety Claims:
  The FDA has historically claimed that genetically engineered foods do not present risks different from traditional foods. However, with long-term interventional studies, such claims may be fully substantiated.

• Public Trust Issues:
  Concerns about government officials' integrity arise when regulatory agencies assert that new technologies are safe without acknowledging the limitations of current understanding. This can undermine public trust in regulatory decisions.

 

Here is an example:

• Coca-Cola and PepsiCo sponsored at least 96 health groups, from the American Diabetes Association (ADA) to the American Heart Association (AHA), between 2011 and 2016

• https://www.ajpmonline.org/article/S0749-3797(16)30331-2/abstract

 

If they don't know, they should say, "We don't know and don't have to prove it." State that it is up to consumer responsibility.​

​​​​

Academia:

• Understanding Symptoms:
  There is a common misunderstanding regarding symptoms like coughing, fever, and inflammation; these are natural defense mechanisms. Healing takes time, and it is crucial not to rush this process with numbing medications. 

• Using numbing medications or painkillers often leads to misunderstandings about health issues, causing individuals to underestimate the severity of their conditions. Many people fail to realize that these medications do not address the underlying causes of pain; instead, they merely mask the symptoms. This can result in a lack of seriousness regarding lifestyle management, including diet and exercise. Pain serves a crucial role in our bodies as an alarm system, signaling that something is wrong and prompting us to take action. It alerts us to potential injuries or health issues, allowing us to address them before they worsen. For instance, when you touch a hot stove, the immediate pain response helps you quickly withdraw your hand, preventing further injury. In this way, pain is not just a discomfort but an essential protective mechanism that encourages healing and self-care. By relying on painkillers to numb this important signal, individuals may ignore the damage occurring within their bodies. This disregard for pain can lead to untreated injuries or chronic conditions that could have been managed more effectively if addressed early on. Ultimately, understanding and respecting the role of pain can foster better health outcomes and encourage proactive management of one’s well-being. 

• Impacts of Conventional Products:
  Conventional foods, drinks, hygiene beauty products, and household products may weaken immune systems and disrupt microbiomes, leaving individuals more vulnerable to health threats and getting sick more often.

We live in a world full of natural toxins, which we have adapted evolutionary. In addition, every year, new chemical compound products are introduced to consumers. "Doctors," who are supposed to be on our side, often act as agents of the pharmaceutical industry. 

 

Politic:

• Transparency in Lobbying:
  The legislative framework allows the public to see who has received lobbying support and which entities have engaged in lobbying activities. Resources for lobbying disclosure include:

  • Lobbying Disclosure Act (LDA) Reports

  • House of Representatives Guide

​​

Medical Institutions:

• What's happened: the more Statins we prescribe, the more heart disease increases. The more Metformin we prescribe, the more diabetes goes up. The more SSRIs (Selective Serotonin Reuptake Inhibitors) we prescribe, the more depression and suicide go up.

• Dr. Philip Pizzo and the influence of pharmaceutical funding on opioid guidelines: Research funding in the medical field predominantly comes from pharmaceutical companies. During his tenure as Dean of Stanford Medical School, Dr. Philip Pizzo accepted a multi-million dollar donation from Pfizer, a leading opioid manufacturer. This funding facilitated the establishment of a new center at Stanford. Subsequently 2011, he was appointed to an NIH panel tasked with developing opioid prescribing guidelines. Notably, Dr. Pizzo appointed 90 individuals to this panel, many of whom had conflicts of interest due to research funding and personal consulting payments from opioid companies. The panel's recommendations contributed to more relaxed standards for opioid prescriptions. Today, it is estimated that 80 to 90 percent of individuals who overdose and die from illicit opioids initially obtained these substances through legal prescriptions. This situation illustrates systemic issues within the healthcare framework. Dr. Pizzo remains at Stanford, raising concerns about a lack of moral clarity and leadership in addressing these conflicts of interest and their implications for public health. 

​

​This business model has taken over Major Regions:

North America: The largest market, with the United States leading the way. The U.S. alone accounts for about 40-45% of global pharmaceutical sales, thanks to its large healthcare system, high drug prices, and a strong focus on innovation and R&D.

Europe: Another significant region, especially in countries like Germany, the UK, France, and Switzerland. Europe accounts for roughly 20-25% of the global pharmaceutical market.

Asia-Pacific: Rapidly expanding, especially in China, India, and Japan. China is now the second-largest pharmaceutical market globally, while India is a major producer of generic medicines.

Latin America, Middle East, and Africa: These regions are growing but represent a smaller share of the total market, with Latin America contributing about 7-8%.​

​

Calley Means, known for his critical analysis of the food industry's economic incentives...

​